04 May 2022>: Clinical Research
Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020
Kwang Ho Mun 1CDEF , Haebong Jang 2ABG , Hwanyeong Jeong 3BC , Jangkyu Choi 4B , June-Woo Lee 5A , Ah-Ra Kim 5CE , Su Hwan Kim 5C , Sung Soon Kim 6A , Donghyok Kwon 7B , Dohsik Minn 8BC , Quehn Park 2ABG*DOI: 10.12659/MSM.934926
Med Sci Monit 2022; 28:e934926
Table 2 Seroprevalence of SARS-CoV-2 antibodies in study subjects and Korean male population.
Region | Study subjects | Korean male population | ||
---|---|---|---|---|
Seropositive | % | PCR positive | % | |
Seoul | 4 | 0.20% (0.06–0.51) | 713 | 0.09% |
Busan | 1 | 0.19% (0.00–1.08) | 62 | 0.02% |
Daegu | 11 | 1.97% (0.99–3.42) | 1,031 | 0.51% |
Incheon | 0 | 0.00% (0.00–0.74) | 96 | 0.04% |
Gwangju | 0 | 0.00% (0.00–1.19) | 63 | 0.05% |
Daejeon | 1 | 0.28% (0.00–1.53) | 37 | 0.03% |
Ulsan | 1 | 0.50% (0.23–2.56) | 24 | 0.02% |
Sejong | 0 | 0.00% (0.00–6.42) | 3 | 0.01% |
Gyeonggi | 6 | 0.23% (0.1–0.50) | 757 | 0.07% |
Gangwon | 0 | 0.00% (0.00–1.63) | 56 | 0.05% |
Chungbuk | 1 | 0.32% (0.01–1.65) | 33 | 0.03% |
Chungnam | 0 | 0.00% (0.00–0.91) | 85 | 0.05% |
Jeonbuk | 1 | 0.33% (0.01–1.72) | 41 | 0.03% |
Jeonnam | 0 | 0.00% (0.00–0.85) | 27 | 0.02% |
Gyeongbuk | 4 | 0.80% (0.27–2.01) | 212 | 0.11% |
Gyeongnam | 1 | 0.19% (0.00–1.04) | 40 | 0.02% |
Jeju | 0 | 0.00% (0.00–1.68) | 13 | 0.03% |
PCR – polymerase chain reaction test; SARS-CoV-2 – severe acute respiratory syndrome coronavirus 2. Data are expressed as n (%), and all of the subjects were Korean male adults, according to Statistics Korea. |